Salvianolic acid D
Kushandiswa kweSalvianolic Acid D
Salvianolic acid D isanganiswa ine inogona kuita antiplatelet basa yakaparadzaniswa neSalvia miltiorrhaza.
Zita reSalvianolic acid D
Zita rechiChinese: Salvianolic acid D
Chirungu Zita: (2R) -2-({(2E)-3-[2-(Carboxymethyl)-3,4-dihydroxyphenyl] -2-propenoyl}oxy) -3-(3,4-dihydroxyphenyl)propanoic acid
Bioactivity yeSalvianolic Acid D
Tsanangudzo:salvianolic acid D musanganiswa unokwanisa kuita antiplatelet wakaparadzaniswa neSalvia miltiorrhiza.
Zvikamu zvinoenderana:research field > > zvimwe
Signal nzira > > zvimwe > > zvimwe
References:[1] Ai CB, nevamwe.Salvianolic Acids D uye E: Maviri Matsva Depsides kubva kuSalvia miltiorrhiza.Planta Med.1992 Apr;58(2):197-9.
Chen Y, nevamwe.A Platelet/CMC yakasanganiswa nekunze UPLC-QTOF-MS/MS yekutarisa antiplatelet chiitiko chezvikamu kubva kune aqueous inotorwa yeDanshen.J Pharm Biomed Anal.2016 Jan 5;117:178-83.
Zvikamu zvinoenderana:research field > > zvimwe
Signal nzira > > zvimwe > > zvimwe
Reference:[1].Ai CB, nevamwe.Salvianolic Acids D uye E: Zvitsva Zvitsva Zviviri kubva kuSalvia miltiorrhiza.Planta Med.1992 Kubvumbi58(2):197-9.
Chen Y, nevamwe.A Platelet/CMC yakasanganiswa nekunze UPLC-QTOF-MS/MS yekutarisa antiplatelet chiitiko chezvikamu kubva kune aqueous inotorwa yeDanshen.J Pharm Biomed Anal.2016 Jan 5;117:178-83.
Physicochemical Properties yeSalvianolic Acid D
Density: 1.6 ± 0.1 g / cm3
Boiling Point: 786.9 ± 60.0 ° C pa 760 mmHg
Molecular Formula: C20h18o10
Molecular uremu: 418.351
Flash Point: 280.2 ± 26.4 ° C
Chaizvo Misa: 418.089996
LogP: 0.98
Steam Pressure: 0.0 ± 2.9 mmHg pa25 ° C
Refractive Index: 1.717
Chirungu Alias yeSalvianolic Acid D
(2R) -2-({(2E)-3-[2-(Carboxymethyl)-3,4-dihydroxyphenyl] -2-propenoyl}oxy) -3-(3,4-dihydroxyphenyl)propanoic acid
Benzenepropanoic acid, α--[[(2E)-3-[2-(carboxymethyl)-3,4-dihydroxyphenyl]-1-oxo-2-propen-1-yl]oxy]-3,4-dihydroxy-, ( αR)-
Iyo kambani Jiangsu Yongjian Pharmaceutical Technology Co., Ltd.
Jiangsu Yongjian Pharmaceutical Technology Co., Ltd., yakavambwa muna Kurume 2012, ibhizimusi repamusoro-soro rinobatanidza R & D, kugadzira nekutengesa.Inonyanya kubatanidzwa mukugadzira, kugadzirisa uye kugadzirwa kwemaitiro ekugadzirwa kwezvinhu zvinoshanda zvezvigadzirwa zvechisikigo, zvechinyakare zveChinese mushonga zvinotaridzwa uye kusvibiswa kwezvinodhaka.Iyo kambani iri muChina Pharmaceutical City, Taizhou Guta, Jiangsu Province, inosanganisira 5000 square metre yekugadzira base uye 2000 square metres R & D base.Iyo inonyanya kushanda masangano makuru ekutsvagisa sainzi, mayunivhesiti uye decoction chidimbu mabhizinesi ekugadzira munyika yose.
Parizvino, takagadzira anopfuura zviuru zana nemazana mashanu emhando dzemasikirwo emakemikari reagents, uye akaenzanisa uye calibrated anopfuura mazana matatu marudzi ereferensi ezvinyorwa, izvo zvinogona kuzadzisa zvizere zvinodiwa zvemazuva ese zvekuongorora zvemasangano makuru esainzi, marabhoritari eyunivhesiti uye decoction zvidimbu zvekugadzira mabhizinesi.
Zvichienderana nemusimboti wekutenda kwakanaka, kambani inotarisira kushanda nemoyo wese nevatengi vedu.Chinangwa chedu ndechekushandira kuvandudzwa kwemishonga yechivanhu yechiChinese.
Advantageous Business Scope yeKambani
1. R & D, kugadzirwa uye kutengesa kwemakemikari ereferensi zvinhu zvechinyakare Chinese mushonga;
2. Customized chinyakare Chinese mushonga monomer compounds maererano mutengi unhu
3. Tsvagiridzo pamusoro pemhando yemhando uye nzira yekuvandudza yechinyakare Chinese mushonga (chirimwa) inotorwa
4. Tekinoroji kubatirana, kutamisa uye kutsvaga zvinodhaka zvitsva nekusimudzira.
